Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer.

Popeda M, Stokowy T, Bednarz-Knoll N, Jurek A, Niemira M, Bielska A, Kretowski A, Kalinowski L, Szade J, Markiewicz A, Zaczek AJ.

Cancers (Basel). 2019 Dec 6;11(12). pii: E1961. doi: 10.3390/cancers11121961.

2.

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy.

Smentoch J, Szade J, Żaczek AJ, Eltze E, Semjonow A, Brandt B, Bednarz-Knoll N.

Cancers (Basel). 2019 Sep 12;11(9). pii: E1356. doi: 10.3390/cancers11091356.

3.

BRCAness in prostate cancer.

Bednarz-Knoll N, Eltze E, Semjonow A, Brandt B.

Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818. eCollection 2019 Mar 29. No abstract available.

4.

ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.

Nastały P, Filipska M, Morrissey C, Eltze E, Semjonow A, Brandt B, Pantel K, Bednarz-Knoll N.

Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.

PMID:
30287243
5.

Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.

Omari A, Nastały P, Stoupiec S, Bałabas A, Dąbrowska M, Bielińska B, Huss S, Pantel K, Semjonow A, Eltze E, Brandt B, Bednarz-Knoll N.

Int J Cancer. 2019 Feb 1;144(3):607-614. doi: 10.1002/ijc.31905. Epub 2018 Oct 22.

6.

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

Obermayr E, Bednarz-Knoll N, Orsetti B, Weier HU, Lambrechts S, Castillo-Tong DC, Reinthaller A, Braicu EI, Mahner S, Sehouli J, Vergote I, Theillet C, Zeillinger R, Brandt B.

Oncotarget. 2017 Nov 16;8(63):106415-106428. doi: 10.18632/oncotarget.22468. eCollection 2017 Dec 5.

7.

Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas.

Bednarz-Knoll N, Efstathiou A, Gotzhein F, Wikman H, Mueller V, Kang Y, Pantel K.

Clin Chem. 2016 Feb;62(2):378-86. doi: 10.1373/clinchem.2015.246686. Epub 2015 Dec 31.

PMID:
26721293
8.

Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.

Bednarz-Knoll N, Nastały P, Żaczek A, Stoupiec MG, Riethdorf S, Wikman H, Müller V, Skokowski J, Szade J, Sejda A, Wełnicka-Jaśkiewicz M, Pantel K.

Oncotarget. 2015 Sep 29;6(29):26789-803. doi: 10.18632/oncotarget.4628.

9.

Circulating tumor cells in patients with testicular germ cell tumors.

Nastały P, Ruf C, Becker P, Bednarz-Knoll N, Stoupiec M, Kavsur R, Isbarn H, Matthies C, Wagner W, Höppner D, Fisch M, Bokemeyer C, Ahyai S, Honecker F, Riethdorf S, Pantel K.

Clin Cancer Res. 2014 Jul 15;20(14):3830-41. doi: 10.1158/1078-0432.CCR-13-2819. Epub 2014 Mar 14.

10.

Plasticity of disseminating cancer cells in patients with epithelial malignancies.

Bednarz-Knoll N, Alix-Panabières C, Pantel K.

Cancer Metastasis Rev. 2012 Dec;31(3-4):673-87. doi: 10.1007/s10555-012-9370-z. Review.

PMID:
22733306
11.

Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

Zaczek A, Markiewicz A, Supernat A, Bednarz-Knoll N, Brandt B, Seroczyńska B, Skokowski J, Szade J, Czapiewski P, Biernat W, Wełnicka-Jaśkiewicz M, Jassem J.

Pathol Oncol Res. 2012 Oct;18(4):885-94. Epub 2012 Mar 18.

12.

Clinical relevance and biology of circulating tumor cells.

Bednarz-Knoll N, Alix-Panabières C, Pantel K.

Breast Cancer Res. 2011;13(6):228. doi: 10.1186/bcr2940. Epub 2011 Nov 1. Review.

Supplemental Content

Loading ...
Support Center